Amino acid replacement: Q269term.
Nucleotide substitution: C1200T.
C6529626T
C1200T
Q275term | eya-PA; Q269term | eya-PB; Q185term | eya-PC
Q269term
abnormal size | adult stage (with eya1)
abnormal size | adult stage (with eya2)
abnormal size | adult stage (with eyacs)
visible | adult stage (with eya1)
visible | adult stage (with eya2)
visible | adult stage (with eya4)
visible | adult stage (with eyacs)
visible | adult stage (with In(2LR)ETD2.2)
eyaE4/eya4 adults and majority of eyaE4/In(2LR)ETD2.2 adults are eyeless.
eya1/eya3 and eya1/eya4 adults exhibit significantly higher number of ommatidia in the eye than eya1/eyaE4 adults.
eya2/eya4 and eya2/eya3 adults exhibit significantly higher number of ommatidia in the eye than eya2/eyaE4 adults.
eyacs/eyaE4 adults exhibit greater number of ommatidia than eyacs/eyacs and eyacs/T(2;3;4)ETD4.3 adults while they exhibit fewer number of ommatidia than eyacs/eya3 and eyacs/eya4 adults.
eyaE4/eya2 has visible | adult stage phenotype, non-enhanceable by Cap-H2Z3-0019/Cap-H2[+]
eyaE4/eya2 has abnormal size | adult stage phenotype, non-enhanceable by Cap-H2Z3-0019/Cap-H2[+]
eyaE4/eya2 has visible | adult stage phenotype, suppressible | partially by Cap-H2Z3-5163/Cap-H2Z3-0019
eyaE4/eya2 has abnormal size | adult stage phenotype, suppressible | partially by Cap-H2Z3-5163/Cap-H2Z3-0019
eyaE4/eya2 has visible | adult stage phenotype, non-suppressible by Cap-H2Z3-0019/Cap-H2[+]
eyaE4/eya2 has abnormal size | adult stage phenotype, non-suppressible by Cap-H2Z3-0019/Cap-H2[+]
eyaE4/eya2 has eye phenotype, non-enhanceable by Cap-H2Z3-0019/Cap-H2[+]
eyaE4/eya2 has eye phenotype, suppressible | partially by Cap-H2Z3-5163/Cap-H2Z3-0019
eyaE4/eya2 has eye phenotype, non-suppressible by Cap-H2Z3-0019/Cap-H2[+]